CAS: 1345675-02-6
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | ETP46464 REF: AN-AG009CBOCAS: 1345675-02-6 | 99% | 228,00 €~490,00 € | Vie 03 May 24 |
 | ETP-46464 REF: TM-T2084CAS: 1345675-02-6 | 99.56% | 40,00 €~430,00 € | Vie 10 May 24 |
 | ETP-46464 REF: 3D-VDC67502CAS: 1345675-02-6 | Min. 95% | A consultar | Vie 14 Jun 24 |
Ref: AN-AG009CBO
| 25mg | 307,00 € | |
| 50mg | 490,00 € |
Entrega estimada en Estados Unidos, el Viernes 3 de Mayo de 2024
ETP-46464
CAS:1345675-02-6
ETP-46464 is an effective and specific ATR inhibitor (IC50: 25 nM).
Fórmula:
C30H22N4O2
Pureza:
99.56%
Forma y color:
Solid
Peso molecular:
470.52
Ref: TM-T2084
| 2mg | 40,00 € | |
| 5mg | 60,00 € | |
| 10mg | 96,00 € | |
| 25mg | 172,00 € | |
| 50mg | 269,00 € | |
| 100mg | 430,00 € | |
| 1ml*10 (DMSO) | 66,00 € |
Entrega estimada en Estados Unidos, el Viernes 10 de Mayo de 2024
ETP-46464
CAS:1345675-02-6
ETP-46464 is a platinum-based chemotherapy agent that is used in the treatment of cancer. It …
Fórmula:
C30H22N4O2
Pureza:
Min. 95%
Peso molecular:
470.52 g/mol
Ref: 3D-VDC67502
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 14 de Junio de 2024
